Clinuvel Pharmaceuticals Ltd
(OTCPK:CLVLY)
$
7.36
+0.010 (+0.14%)
Market Cap: 371.17 Mil
Enterprise Value: 209.93 Mil
PE Ratio: 17.44
PB Ratio: 2.07
GF Score: 84/100 Clinuvel Pharmaceuticals Ltd Corporate Presentation Transcript
Oct 25, 2021 / 06:00AM GMT
Release Date Price:
$29.29
(+0.06%)
Malcolm Bull
CLINUVEL Pharmaceuticals Ltd - Head of IR
I'm Malcolm Bull, Head of Investor Relations, and I'd like to welcome all participants, and indeed, our Managing Director, Dr. Wolgen, to this webinar. We're holding this webinar to provide an opportunity to stakeholders, to ask questions on the what, how and when of our business.
As long-term shareholders know, we frequently provide updates on the company in our news and scientific communiques. But in the virtual world we've been living in for the past two years, not everyone has had the opportunity to review and ask questions on CLINUVEL's operations.
In addition to the time allocated to questions at the forthcoming Annual General Meeting, we wanted to provide stakeholders with another opportunity to raise their questions. And
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot